175 related articles for article (PubMed ID: 38272554)
1. Artificial intelligence-supported diabetic retinopathy screening in Tanzania: rationale and design of a randomised controlled trial.
Cleland CR; Bascaran C; Makupa W; Shilio B; Sandi FA; Philippin H; Marques AP; Egan C; Tufail A; Keane PA; Denniston AK; Macleod D; Burton MJ
BMJ Open; 2024 Jan; 14(1):e075055. PubMed ID: 38272554
[TBL] [Abstract][Full Text] [Related]
2. Individualised screening for diabetic retinopathy: the ISDR study-rationale, design and methodology for a randomised controlled trial comparing annual and individualised risk-based variable-interval screening.
Broadbent DM; Sampson CJ; Wang A; Howard L; Williams AE; Howlin SU; Appelbe D; Moitt T; Cheyne CP; Rahni MM; Kelly J; Collins J; García-Fiñana M; Stratton IM; James M; Harding SP;
BMJ Open; 2019 Jun; 9(6):e025788. PubMed ID: 31213445
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 21 artificial intelligence algorithms in automated diabetic retinopathy screening using handheld fundus camera.
Kubin AM; Huhtinen P; Ohtonen P; Keskitalo A; Wirkkala J; Hautala N
Ann Med; 2024 Dec; 56(1):2352018. PubMed ID: 38738798
[TBL] [Abstract][Full Text] [Related]
4. Impact of Artificial Intelligence Assessment of Diabetic Retinopathy on Referral Service Uptake in a Low-Resource Setting: The RAIDERS Randomized Trial.
Mathenge W; Whitestone N; Nkurikiye J; Patnaik JL; Piyasena P; Uwaliraye P; Lanouette G; Kahook MY; Cherwek DH; Congdon N; Jaccard N
Ophthalmol Sci; 2022 Dec; 2(4):100168. PubMed ID: 36531575
[TBL] [Abstract][Full Text] [Related]
5. Validation of Deep Convolutional Neural Network-based algorithm for detection of diabetic retinopathy - Artificial intelligence versus clinician for screening.
Shah P; Mishra DK; Shanmugam MP; Doshi B; Jayaraj H; Ramanjulu R
Indian J Ophthalmol; 2020 Feb; 68(2):398-405. PubMed ID: 31957737
[TBL] [Abstract][Full Text] [Related]
6. Real-world artificial intelligence-based opportunistic screening for diabetic retinopathy in endocrinology and indigenous healthcare settings in Australia.
Scheetz J; Koca D; McGuinness M; Holloway E; Tan Z; Zhu Z; O'Day R; Sandhu S; MacIsaac RJ; Gilfillan C; Turner A; Keel S; He M
Sci Rep; 2021 Aug; 11(1):15808. PubMed ID: 34349130
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a novel artificial intelligence-based screening system for diabetic retinopathy in community of China: a real-world study.
Ming S; Xie K; Lei X; Yang Y; Zhao Z; Li S; Jin X; Lei B
Int Ophthalmol; 2021 Apr; 41(4):1291-1299. PubMed ID: 33389425
[TBL] [Abstract][Full Text] [Related]
8. Application of artificial intelligence-based dual-modality analysis combining fundus photography and optical coherence tomography in diabetic retinopathy screening in a community hospital.
Liu R; Li Q; Xu F; Wang S; He J; Cao Y; Shi F; Chen X; Chen J
Biomed Eng Online; 2022 Jul; 21(1):47. PubMed ID: 35859144
[TBL] [Abstract][Full Text] [Related]
9. EyeArt artificial intelligence analysis of diabetic retinopathy in retinal screening events.
Vought R; Vought V; Shah M; Szirth B; Bhagat N
Int Ophthalmol; 2023 Dec; 43(12):4851-4859. PubMed ID: 37847478
[TBL] [Abstract][Full Text] [Related]
10. Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study.
Lois N; Cook J; Wang A; Aldington S; Mistry H; Maredza M; McAuley D; Aslam T; Bailey C; Chong V; Ghanchi F; Scanlon P; Sivaprasad S; Steel D; Styles C; Azuara-Blanco A; Prior L; Waugh N
Health Technol Assess; 2021 May; 25(32):1-104. PubMed ID: 34060440
[TBL] [Abstract][Full Text] [Related]
11. An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectiveness.
Tufail A; Kapetanakis VV; Salas-Vega S; Egan C; Rudisill C; Owen CG; Lee A; Louw V; Anderson J; Liew G; Bolter L; Bailey C; Sadda S; Taylor P; Rudnicka AR
Health Technol Assess; 2016 Dec; 20(92):1-72. PubMed ID: 27981917
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Accuracy of Automated Diabetic Retinopathy Image Assessment Softwares: IDx-DR and Medios Artificial Intelligence.
Grzybowski A; Rao DP; Brona P; Negiloni K; Krzywicki T; Savoy FM
Ophthalmic Res; 2023; 66(1):1286-1292. PubMed ID: 37757777
[TBL] [Abstract][Full Text] [Related]
13. Validation of Automated Screening for Referable Diabetic Retinopathy With an Autonomous Diagnostic Artificial Intelligence System in a Spanish Population.
Shah A; Clarida W; Amelon R; Hernaez-Ortega MC; Navea A; Morales-Olivas J; Dolz-Marco R; Verbraak F; Jorda PP; van der Heijden AA; Peris Martinez C
J Diabetes Sci Technol; 2021 May; 15(3):655-663. PubMed ID: 32174153
[TBL] [Abstract][Full Text] [Related]
14. The Value of Automated Diabetic Retinopathy Screening with the EyeArt System: A Study of More Than 100,000 Consecutive Encounters from People with Diabetes.
Bhaskaranand M; Ramachandra C; Bhat S; Cuadros J; Nittala MG; Sadda SR; Solanki K
Diabetes Technol Ther; 2019 Nov; 21(11):635-643. PubMed ID: 31335200
[No Abstract] [Full Text] [Related]
15. Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data.
Lin S; Ma Y; Xu Y; Lu L; He J; Zhu J; Peng Y; Yu T; Congdon N; Zou H
JMIR Public Health Surveill; 2023 Feb; 9():e41624. PubMed ID: 36821353
[TBL] [Abstract][Full Text] [Related]
16. Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study.
Bellemo V; Lim ZW; Lim G; Nguyen QD; Xie Y; Yip MYT; Hamzah H; Ho J; Lee XQ; Hsu W; Lee ML; Musonda L; Chandran M; Chipalo-Mutati G; Muma M; Tan GSW; Sivaprasad S; Menon G; Wong TY; Ting DSW
Lancet Digit Health; 2019 May; 1(1):e35-e44. PubMed ID: 33323239
[TBL] [Abstract][Full Text] [Related]
17. THEIA™ development, and testing of artificial intelligence-based primary triage of diabetic retinopathy screening images in New Zealand.
Vaghefi E; Yang S; Xie L; Hill S; Schmiedel O; Murphy R; Squirrell D
Diabet Med; 2021 Apr; 38(4):e14386. PubMed ID: 32794618
[TBL] [Abstract][Full Text] [Related]
18. Medios- An offline, smartphone-based artificial intelligence algorithm for the diagnosis of diabetic retinopathy.
Sosale B; Sosale AR; Murthy H; Sengupta S; Naveenam M
Indian J Ophthalmol; 2020 Feb; 68(2):391-395. PubMed ID: 31957735
[TBL] [Abstract][Full Text] [Related]
19. What are the perceptions and concerns of people living with diabetes and National Health Service staff around the potential implementation of AI-assisted screening for diabetic eye disease? Development and validation of a survey for use in a secondary care screening setting.
Willis K; Chaudhry UAR; Chandrasekaran L; Wahlich C; Olvera-Barrios A; Chambers R; Bolter L; Anderson J; Barman SA; Fajtl J; Welikala R; Egan C; Tufail A; Owen CG; Rudnicka A; ;
BMJ Open; 2023 Nov; 13(11):e075558. PubMed ID: 37968006
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
